Arch Therapeutics Inc (ARTHQ)

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. It's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wo...